lenograstim

CSF3

A gene on chromosome 17q11.2-q12 that encodes colony stimulating factor 3 (granulocyte), a cytokine that controls the production, differentiation and function of granulocytes, the active protein product of which is located extracellularly.

lenograstim

Human GRANULOCYTE-STIMULATING FACTOR produced by genetic engineering and used to treat severe deficiencies of some of the white cells of the blood and the immune system. A brand name is Granocyte.
Mentioned in ?
References in periodicals archive ?
Contract notice: conclusion of non-exclusive discount agreements pursuant to section 130a (8) sgb v on medicines containing the active substance lenograstim (atc: l03aa10) as part of a so-called open-house model.
contracts for the active substance lenograstim (atc: l03aa10) will be concluded for the first time with effect from 01.
Granocyte Lenograstim Injection 34 million units/ml in Vial Trade names Pack size Price (MRP) Company names Myleran 100's/Box 828.
Contract Award Notice: The supply of Lenograstim (Granocyte) to Health Boards across NHS Scotland.
3, ATC Code: L0310, Generic Name: Lenograstim, pharmaceutical form: injection Strength: 100-300 micrograms Unit Value: 0.